GILD FDA calendar & decision history Gilead Sciences Inc. · 3 upcoming · 5 past FDA decisions
Upcoming FDA catalysts GILD · Aug 27, 2026 Bictegravir and Lenacapavir - (ARTISTRY-2) — HIV GILD · Dec 23, 2026 FDA decision GILD · Feb 2, 2027 FDA decision FDA decision history (5) Jun 24, 2026✓ Approved Trodelvy (sacituzumab goviteca May 26, 2026✓ Approved Hepcludex (Bulevirtide) - (MYR Feb 6, 2026✓ Approved YESCARTA - Axicabtagene cilole Dec 16, 2025✓ Approved FDA decision Jun 18, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates GILD's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio